ArticleRMD open2023

Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA).

Maxime Dougados et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.